Last Hilo valuation
$48M
Pre-seed · Dec 2023
Last Hilo funding round
$19M
Series B · Jul 2026
Cumulative funding Hilo raised
$121M
across 7 funding rounds
Key investors in Hilo
redalpine
Translink Capital
Verve Ventures
Molten Ventures
Khosla Ventures
415 Capital
About Hilo
Hilo is a digital health company delivering a cuffless blood pressure monitoring platform. The wrist-worn device employs photoplethysmography sensors and machine learning models to capture systolic and diastolic readings every 90 minutes around the clock, even during sleep. Paired with a mobile app, it shares trends and alerts with users and physicians via electronic health records integration. Paris-headquartered Hilo targets hypertension patients and holds regulatory approvals in Europe for its continuous monitoring technology.
Founded
2018
HQ
NeuchâtelWebsite
Status
Privately held
Customer focus
B2C
Revenue model
Product sales
Valuation
$48M (Dec 2023)
Hilo Valuation
Hilo is currently valued at $48M, based on its pre-seed round in December 2023.
The $1M round included Crowdcube.
Hilo valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Dec 2023 | Pre-seed | $48M |
Hilo Funding History
Hilo has raised a total of $121M across 7 funding rounds.
Hilo's first fundraising round was a $4M seed round in September 2018. The most recent completed round was a $19M Series B in July 2026.
Hilo funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jul 2026 | Series B | DFO Management (lead) | $19M | - | - |
| May 2025 | Series B | Earlybird VC (lead); Wellington Partners (lead); redalpine; naturalX Health Ventures; K Fund; Khosla Ventures; Molten Ventures; Verve Ventures; Translink Capital | $42M | - | Hilo, formerly Aktiia, is a blood pressure intelligence platform specializing in cuffless blood pressure monitoring (CBPM) using wearable devices and smartphone camera technology for frequent, accurate measurements. The company rebranded to Hilo alongside announcing an oversubscribed $42 million Series B funding round on May 1, 2025, co-led by Earlybird Health (Earlybird Venture Capital) and Wellington Partners, with new investors K Fund (Kfund) and naturalX Health Ventures, and participation from existing investors Khosla Ventures, Molten Ventures, redalpine, Translink Capital, and Verve Ventures. This round brought total funding to over $100 million. The proceeds will fuel product innovation, expansion into new markets including Germany, development of enterprise use cases, new marketing channels, and preparation for U.S. FDA submission following a pivotal clinical trial. Hilo has achieved regulatory approvals with CE marking for mobile phone camera BP monitoring, and clearances in Canada, Australia, and Saudi Arabia. It reported 76% compounded annual revenue growth and has sold over 120,000 devices, training its proprietary ML model on billions of optical signals and hundreds of millions of calibration points, backed by over 120 peer-reviewed publications and 35+ patents. Hilo positions itself as a leader in addressing global hypertension affecting billions, with only 20% under control, by providing seamless, real-time monitoring. Christoph Massner from Earlybird Health joined the board, praising the blend of medical-grade precision and user accessibility. Investors highlighted the technology's potential to transform blood pressure management. |
| Feb 2024 | Series A | redalpine (lead); Khosla Ventures; Molten Ventures; Verve Ventures; Translink Capital; 415 Capital | $31M | - | - |
| Dec 2023 | Pre-seed | Crowdcube | $1M | $48M | Hilo is a cuffless blood-pressure monitoring wearable technology company. The company raised $42 million in its Series B round in May 2025 led by Earlybird Health, Wellington Partners, and Kfund. |
| Nov 2021 | Series A | Molten Ventures (lead); redalpine; Verve Ventures; Translink Capital; 415 Capital | $18M | - | - |
| Mar 2020 | Seed | redalpine (lead); Mladen Barbaric; Christian Wenger; Sparks Street Capital; Verve Ventures; Translink Capital; Humanco | $6M | - | - |
| Sep 2018 | Seed | Translink Capital (lead); redalpine; Mladen Barbaric; Christian Wenger; Sparks Street Capital | $4M | - | - |
Who has invested in Hilo?
16 investors have backed Hilo across its funding rounds, including redalpine, Translink Capital, Verve Ventures, Molten Ventures, Khosla Ventures and 415 Capital.
Lead investors include DFO Management, Earlybird VC, Wellington Partners, redalpine, Molten Ventures and 1 other investor.
Hilo Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| Zurich | 5 | Lead | Sep 2018 | |
 San Francisco, CA | 5 | Lead | Sep 2018 | |
| Zug | 4 | Participant | Mar 2020 | |
 London | 3 | Lead | Nov 2021 | |
 Montreal | 2 | Participant | Sep 2018 | |
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Christian Wenger | Zurich | 2 | Participant | Sep 2018 |
| San Francisco, CA | 2 | Participant | Feb 2024 | |
| Sparks Street Capital | -- | 2 | Participant | Sep 2018 |
 Germany | 2 | Participant | Nov 2021 | |
| Berlin | 1 | Participant | May 2025 | |
| New York City, NY | 1 | Lead | Jul 2026 | |
| Exeter | 1 | Participant | Dec 2023 | |
 Madrid | 1 | Participant | May 2025 | |
This data is available for Pro users. Sign up to see all 16 Hilo investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialHilo Competitors
Hilo competitors include listed companies like Zepp Health and NurExone Biologic, and private ones like Neurable, Intelligent Haptronic Solutions, HealthWatch Technologies and NeuroBionics.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Boston, MA | Private | - | - | $41M | - | |
| Vancouver | Private | - | - | $61M | - | |
 Israel | Private | - | - | $65M | - | |
| United States | Private | - | - | $33M | - | |
 Netherlands | Publicly listed | $259M | ($27M) | $65M | 0.8x | |
| Canada | Publicly listed | - | ($6M) | $48M | - |
Hilo Public Comps
Hilo is still privately-owned, but its public comps include Senzime, Ceretas, Svas Biosana, NurExone Biologic, SMAIO, Xtant Medical, Susmed, Klea, Renalytix and Sensus Healthcare.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $11M | ($12M) | 4.4x | 3.7x | (4.0x) | (6.9x) | |||
| - | - | - | - | - | - | |||
| $163M | $22M | 0.7x | 0.7x | 5.1x | 5.1x | |||
| - | ($6M) | - | - | (7.6x) | - | |||
| $11M | ($1M) | 4.4x | 3.8x | (41.5x) | (39.3x) | |||
| $134M | $16M | 0.5x | 0.6x | 3.9x | (434.3x) | |||
| $3M | ($2M) | 7.4x | 5.6x | (11.8x) | - | |||
| $26M | $6M | 2.0x | - | 8.7x | - | |||
This data is available for Pro users. Sign up to see all Hilo competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Hilo
| When was Hilo founded? | Hilo was founded in 2018. |
| Where is Hilo headquartered? | Hilo is headquartered in Neuchâtel, Switzerland. |
| Is Hilo publicly listed? | No, Hilo is a private, VC-backed company. |
| What is Hilo's valuation? | Hilo was last valued at $48M in its pre-seed round in December 2023. |
| How much funding has Hilo raised? | Hilo has raised $121M across 7 funding rounds. |
| What was Hilo's last funding round? | Hilo's last funding round was a $19M Series B in July 2026, led by DFO Management. |
| Who are Hilo's investors? | Hilo's investors include redalpine, Translink Capital, Verve Ventures, Molten Ventures, Mladen Barbaric, Christian Wenger, Khosla Ventures, Sparks Street Capital, 415 Capital, naturalX Health Ventures and 6 others. |
| Which companies are comparable to Hilo? | Companies comparable to Hilo include Neurable, Intelligent Haptronic Solutions, HealthWatch Technologies, NeuroBionics, Zepp Health and NurExone Biologic. |
See companies similar to Hilo
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.